How protein-based COVID vaccines could change the pandemic
Elie Dolgin • November 8, 2021
Jabs from Novavax and other biotech firms are coming. Scientists say they have a lot to offer.
Continue reading at Nature.
Pixels meet paint, as a digital “mask” conceals damage on a 15th-century painting.
Options are emerging for the tens of millions of people who stop taking GLP-1 drugs because of side effects, cost or availability.